1. Long-term administration of pegylated liposomal doxorubicin at almost twice the recommended lifetime dose in 10 years without cardiotoxicity in a Japanese patient with HIV-associated Kaposi sarcoma. Issue 2 (February 2020) Authors: Yokota, Kazuhisa; Yotsumoto, Mihoko; Muramatsu, Takashi; Saito, Masuyoshi; Kamikubo, Yoshiko; Ichiki, Akito; Chikasawa, Yushi; Bingo, Masato; Hagiwara, Takeshi; Amano, Kagehiro; Fukutake, Katsuyuki Journal: Journal of infection and chemotherapy Issue: Volume 26:Issue 2(2020:Feb.) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions. (15th November 2020) Authors: Yotsumoto, Mihoko; Hachiya, Atsuko; Ichiki, Akito; Amano, Kagehiro; Kinai, Ei Journal: AIDS Issue: Volume 34:Number 14(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIV. Issue 2 (February 2023) Authors: Sekiya, Ryoko; Muramatsu, Takashi; Ichiki, Akito; Chikasawa, Yushi; Bingo, Masato; Yotsumoto, Mihoko; Hagiwara, Takeshi; Amano, Kagehiro; Kinai, Ei Journal: Journal of infection and chemotherapy Issue: Volume 29:Issue 2(2023) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗